Arterial Stiffness and Influences of the Metabolic Syndrome: a Cross-countries Study

Specific clusters of metabolic syndrome (MetS) components impact differentially on arterial stiffness, indexed as pulse wave velocity (PWV). Of note, in several population-based studies participating in the MARE (Metabolic syndrome and Arteries REsearch) Consortium the occurrence of specific clusters of MetS differed markedly across Europe and the US. The aim of the present study was to investigate whether specific clusters of MetS are consistently associated with stiffer arteries in different populations. We studied 20,570 subjects from 9 cohorts representing 8 different European countries and the US participating in the MARE Consortium. MetS was defined in accordance with NCEP ATPIII criteria as the simultaneous alteration in ≥3 of the 5 components: abdominal obesity (W), high triglycerides (T), low HDL cholesterol (H), elevated blood pressure (B), and elevated fasting glucose (G). PWV measured in each cohort was "normalized" to account for different acquisition methods. MetS had an overall prevalence of 24.2% (4985 subjects). MetS accelerated the age-associated increase in PWV levels at any age, and similarly in men and women. MetS clusters TBW, GBW, and GTBW are consistently associated with significantly stiffer arteries to an extent similar or greater than observed in subjects with alteration in all the five MetS components--even after controlling for age, sex, smoking, cholesterol levels, and diabetes mellitus--in all the MARE cohorts. In conclusion, different component clusters of MetS showed varying associations with arterial stiffness (PWV).

Citing Articles

Metabolic syndrome in the prison population: new lines of intervention.

Romero-Marco P, Beddar Chaib F, Fernandez-Araque A Rev Esp Sanid Penit. 2025; 26(3):79-81.

PMID: 39927804 PMC: 11632553. DOI: 10.18176/resp.00092.

Differences of Sedentary Behavior, Physical Activity, and Metabolic Syndrome Severity Among Metabolic Syndrome Clusters.

Booker R, Jones R, Galloway R, Holmes M Am J Lifestyle Med. 2025; 19(1):88-98.

PMID: 39822323 PMC: 11733097. DOI: 10.1177/15598276211056874.

Aortic pulse wave velocity predicts cardiovascular mortality among middle-aged metabolic syndrome subjects without overt cardiovascular disease.

Juceviciene A, Puronaite R, Badariene J, Ryliskyte L Nutr Metab (Lond). 2024; 21(1):98.

PMID: 39617940 PMC: 11610092. DOI: 10.1186/s12986-024-00875-z.

Arterial Stiffness, Body Mass Index and Cardiovascular Disease Risk in Chinese Females at Various Ages.

Jin L, Du Y, Zhang M, Chen J, Sha L, Cao M Rev Cardiovasc Med. 2024; 24(5):144.

PMID: 39076754 PMC: 11273021. DOI: 10.31083/j.rcm2405144.

Glucose-6-phosphate dehydrogenase deficiency accelerates arterial aging in diabetes.

Scuteri A, Morrell C, Alghatrif M, Orru M, Fiorillo E, Marongiu M Acta Diabetol. 2023; 61(1):127-130.

PMID: 37741911 PMC: 10805791. DOI: 10.1007/s00592-023-02118-8.

References

Gorelick P, Scuteri A, Black S, DeCarli C, Greenberg S, Iadecola C . Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke. 2011; 42(9):2672-713. PMC: 3778669. DOI: 10.1161/STR.0b013e3182299496. View

Weber T, Ammer M, Rammer M, Adji A, ORourke M, Wassertheurer S . Noninvasive determination of carotid-femoral pulse wave velocity depends critically on assessment of travel distance: a comparison with invasive measurement. J Hypertens. 2009; 27(8):1624-30. DOI: 10.1097/HJH.0b013e32832cb04e. View

Lin H, Liu C, Liao Y, Lin R, Chen C, Juo S . The risk of the metabolic syndrome on carotid thickness and stiffness: sex and age specific effects. Atherosclerosis. 2009; 210(1):155-9. DOI: 10.1016/j.atherosclerosis.2009.11.027. View

Scuteri A, Lakatta E . Bringing prevention in geriatrics: evidences from cardiovascular medicine supporting the new challenge. Exp Gerontol. 2012; 48(1):64-8. PMC: 4521763. DOI: 10.1016/j.exger.2012.02.009. View

Gami A, Witt B, Howard D, Erwin P, Gami L, Somers V . Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol. 2007; 49(4):403-14. DOI: 10.1016/j.jacc.2006.09.032. View

Mahajan A, Jaiswal A, Tabassum R, Podder A, Ghosh S, Madhu S . Elevated levels of C-reactive protein as a risk factor for metabolic syndrome in Indians. Atherosclerosis. 2011; 220(1):275-81. DOI: 10.1016/j.atherosclerosis.2011.10.031. View

Tuttolomondo A, Di Raimondo D, Di Sciacca R, Pecoraro R, Arnao V, Butta C . Arterial stiffness and ischemic stroke in subjects with and without metabolic syndrome. Atherosclerosis. 2012; 225(1):216-9. DOI: 10.1016/j.atherosclerosis.2012.08.027. View

Scuteri A, Orru M, Morrell C, Tarasov K, Schlessinger D, Uda M . Associations of large artery structure and function with adiposity: effects of age, gender, and hypertension. The SardiNIA Study. Atherosclerosis. 2012; 221(1):189-97. PMC: 3713416. DOI: 10.1016/j.atherosclerosis.2011.11.045. View

Scuteri A, Tesauro M, Appolloni S, Preziosi F, Brancati A, Volpe M . Arterial stiffness as an independent predictor of longitudinal changes in cognitive function in the older individual. J Hypertens. 2007; 25(5):1035-40. DOI: 10.1097/HJH.0b013e3280895b55. View

10.

Scuteri A, Najjar S, Muller D, Andres R, Hougaku H, Metter E . Metabolic syndrome amplifies the age-associated increases in vascular thickness and stiffness. J Am Coll Cardiol. 2004; 43(8):1388-95. DOI: 10.1016/j.jacc.2003.10.061. View

11.

Juonala M, Saarikoski L, Viikari J, Oikonen M, Lehtimaki T, Lyytikainen L . A longitudinal analysis on associations of adiponectin levels with metabolic syndrome and carotid artery intima-media thickness. The Cardiovascular Risk in Young Finns Study. Atherosclerosis. 2011; 217(1):234-9. DOI: 10.1016/j.atherosclerosis.2011.03.016. View

12.

Scuteri A, Najjar S, Morrell C, Lakatta E . The metabolic syndrome in older individuals: prevalence and prediction of cardiovascular events: the Cardiovascular Health Study. Diabetes Care. 2005; 28(4):882-7. DOI: 10.2337/diacare.28.4.882. View

13.

Redon J, Cifkova R, Laurent S, Nilsson P, Narkiewicz K, Erdine S . The metabolic syndrome in hypertension: European society of hypertension position statement. J Hypertens. 2008; 26(10):1891-900. DOI: 10.1097/HJH.0b013e328302ca38. View

14.

Najjar S, Scuteri A, Lakatta E . Arterial aging: is it an immutable cardiovascular risk factor?. Hypertension. 2005; 46(3):454-62. DOI: 10.1161/01.HYP.0000177474.06749.98. View

15.

Di Pino A, Alagona C, Piro S, Calanna S, Spadaro L, Palermo F . Separate impact of metabolic syndrome and altered glucose tolerance on early markers of vascular injuries. Atherosclerosis. 2012; 223(2):458-62. DOI: 10.1016/j.atherosclerosis.2012.05.008. View

16.

Scuteri A, Nilsson P, Tzourio C, Redon J, Laurent S . Microvascular brain damage with aging and hypertension: pathophysiological consideration and clinical implications. J Hypertens. 2011; 29(8):1469-77. DOI: 10.1097/HJH.0b013e328347cc17. View

17.

Sattar N, McConnachie A, Shaper A, Blauw G, Buckley B, de Craen A . Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies. Lancet. 2008; 371(9628):1927-35. DOI: 10.1016/S0140-6736(08)60602-9. View

18.

Mottillo S, Filion K, Genest J, Joseph L, Pilote L, Poirier P . The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol. 2010; 56(14):1113-32. DOI: 10.1016/j.jacc.2010.05.034. View

19.

Khang Y, Cho S, Kim H . Risks for cardiovascular disease, stroke, ischaemic heart disease, and diabetes mellitus associated with the metabolic syndrome using the new harmonised definition: findings from nationally representative longitudinal data from an Asian population. Atherosclerosis. 2010; 213(2):579-85. DOI: 10.1016/j.atherosclerosis.2010.09.009. View

20.

Freimer N, Sabatti C . The human phenome project. Nat Genet. 2003; 34(1):15-21. DOI: 10.1038/ng0503-15. View